Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

People undergoing chemotherapy need better support and information to cope with hair loss.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.